Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
General Internal Medicine
•
Rheumatology
•
Hematology
•
Pediatric Hematology
•
Lupus nephritis
•
Antiphospholipid Syndrome
•
Nephrology
•
Glomerulonephritis
•
Anticoagulation
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
Related Questions
How do you approach the management of patients with suspected membranous lupus nephritis who are found to have positive PLA2R antibodies?
Can lupus anticoagulant be positive despite a normal aPTT?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?
What do you feel are the potential barriers to widespread use of obinutuzumab in proliferative lupus nephritis?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Do you recommend initiating immunosuppression and plasmapheresis in patients with dialysis dependent AKI in the setting of anti-GBM disease who do not have pulmonary involvement?
How should clinicians approach the decision to use apixaban, or other DOACs, in pediatric patients with acute lymphoblastic leukemia or lymphoma who have additional risk factors for VTE, such as obesity or a family history of thrombosis, given the negative outcome of the PREVAPIX-ALL trial?
Which classes of medications are reasonable to consider in cases of acute pericarditis in a patient with G6PD deficiency?